Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 7, Pages 1637
Publisher
MDPI AG
Online
2019-04-03
DOI
10.3390/ijms20071637
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer
- (2018) Sasha C. Druskin et al. BJU INTERNATIONAL
- The “PROMIS” of Magnetic Resonance Imaging Cost Effectiveness in Prostate Cancer Diagnosis?
- (2018) Jochen Walz EUROPEAN UROLOGY
- The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential
- (2018) Peter Ström et al. EUROPEAN UROLOGY
- Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging
- (2018) Henrik Grönberg et al. EUROPEAN UROLOGY
- DLX1, a binding protein of beta-catenin, promoted the growth and migration of prostate cancer cells
- (2018) Ming Liang et al. EXPERIMENTAL CELL RESEARCH
- Accuracy of transperineal targeted prostate biopsies, both visual-estimation and image-fusion for men needing a repeat biopsy in the PICTURE trial
- (2018) Lucy A.M. Simmons et al. JOURNAL OF UROLOGY
- Incorporating biomarkers into the primary prostate biopsy setting: a cost-effectiveness analysis
- (2018) Niranjan J. Sathianathen et al. JOURNAL OF UROLOGY
- MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
- (2018) Veeru Kasivisvanathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fusion prostate biopsy outperforms 12-core systematic prostate biopsy in patients with prior negative systematic biopsy: A multi-institutional analysis
- (2018) Abhinav Sidana et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Positive pre-biopsy MRI: are systematic biopsies still useful in addition to targeted biopsies?
- (2018) Guillaume Ploussard et al. WORLD JOURNAL OF UROLOGY
- A Magnetic Resonance Imaging–Based Prediction Model for Prostate Biopsy Risk Stratification
- (2018) Sherif Mehralivand et al. JAMA Oncology
- Novel diagnostic biomarkers of prostate cancer: an update
- (2018) Umberto Anceschi et al. CURRENT MEDICINAL CHEMISTRY
- Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators
- (2018) Arnout R. Alberts et al. EUROPEAN UROLOGY
- Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study
- (2018) Louise Clare Brown et al. HEALTH TECHNOLOGY ASSESSMENT
- Optimizing patient's selection for prostate biopsy: A single institution experience with multi-parametric MRI and the 4Kscore test for the detection of aggressive prostate cancer
- (2018) Sanoj Punnen et al. PLoS One
- Cost-effectiveness of SelectMDx for prostate cancer in four European countries: a comparative modeling study
- (2018) Tim M. Govers et al. PROSTATE CANCER AND PROSTATIC DISEASES
- The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohort
- (2018) Axel Möller et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Extended follow-up for prostate cancer incidence and mortality among participants in the Prostate, Lung, Colorectal and Ovarian randomized cancer screening trial
- (2018) Paul F. Pinsky et al. BJU INTERNATIONAL
- A Multicentre Evaluation of the Role of the Prostate Health Index (PHI) in Regions with Differing Prevalence of Prostate Cancer: Adjustment of PHI Reference Ranges is Needed for European and Asian Settings
- (2018) Peter K.-F. Chiu et al. EUROPEAN UROLOGY
- Results of Prostate Cancer Screening in a Unique Cohort at 19 yr of Follow-up
- (2018) Daniël F. Osses et al. EUROPEAN UROLOGY
- The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies
- (2018) Olivier Wegelin et al. EUROPEAN UROLOGY
- Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study
- (2018) Marloes van der Leest et al. EUROPEAN UROLOGY
- Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study
- (2018) Olivier Rouvière et al. LANCET ONCOLOGY
- Reducing unnecessary biopsies while detecting clinically significant prostate cancer including cribriform growth with the ERSPC Rotterdam risk calculator and 4Kscore
- (2018) Jan F.M. Verbeek et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Diagnostic Pathway with Multiparametric Magnetic Resonance Imaging Versus Standard Pathway: Results from a Randomized Prospective Study in Biopsy-naïve Patients with Suspected Prostate Cancer
- (2017) Francesco Porpiglia et al. EUROPEAN UROLOGY
- What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel
- (2017) Paul C. Moldovan et al. EUROPEAN UROLOGY
- Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth
- (2017) Monique J. Roobol et al. EUROPEAN UROLOGY
- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
- (2017) Nicolas Mottet et al. EUROPEAN UROLOGY
- Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer—Patient-tailored Risk Stratification Can Reduce Unnecessary Biopsies
- (2017) Jan Philipp Radtke et al. EUROPEAN UROLOGY
- Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
- (2017) Hashim U Ahmed et al. LANCET
- A urinary biomarker-based risk score correlates with multiparametric MRI for prostate cancer detection
- (2017) Rianne J. Hendriks et al. PROSTATE
- Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer
- (2017) Tobias Nordström et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Risk Stratification by Urinary Prostate Cancer Gene 3 Testing Before Magnetic Resonance Imaging-Ultrasound Fusion-targeted Prostate Biopsy Among Men With No History of Biopsy
- (2017) Michael Fenstermaker et al. UROLOGY
- Magnetic Resonance Imaging Provides Added Value to the Prostate Cancer Prevention Trial Risk Calculator for Patients With Estimated Risk of High-grade Prostate Cancer Less Than or Equal to 10%
- (2017) Eric H. Kim et al. UROLOGY
- ‘Prostate Cancer Risk Calculator’ mobile applications (Apps): a systematic review and scoring using the validated user version of the Mobile Application Rating Scale (uMARS)
- (2017) Ahmed Adam et al. WORLD JOURNAL OF UROLOGY
- Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer
- (2016) Stacy Loeb et al. BJU INTERNATIONAL
- European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators significantly outperform the Prostate Cancer Prevention Trial (PCPT) 2.0 in the prediction of prostate cancer: a multi-institutional study
- (2016) Robert W. Foley et al. BJU INTERNATIONAL
- Beyond prostate-specific antigen
- (2016) Stacy Loeb et al. CURRENT OPINION IN UROLOGY
- Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment
- (2016) Scott A. Tomlins et al. EUROPEAN UROLOGY
- Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans
- (2016) Arnout R. Alberts et al. EUROPEAN UROLOGY
- Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker–Based Risk Score
- (2016) Leander Van Neste et al. EUROPEAN UROLOGY
- PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2
- (2016) Jeffrey C. Weinreb et al. EUROPEAN UROLOGY
- NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016
- (2016) Peter R. Carroll et al. Journal of the National Comprehensive Cancer Network
- Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR
- (2016) Andrew B. Rosenkrantz et al. JOURNAL OF UROLOGY
- The Prostate Health Index adds predictive value to multi-parametric MRI in detecting significant prostate cancers in a repeat biopsy population
- (2016) V. J. Gnanapragasam et al. Scientific Reports
- The percentage of prostate-specific antigen (PSA) isoform [-2]proPSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA in men
- (2015) Martin Boegemann et al. BJU INTERNATIONAL
- Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer
- (2015) G. H. J. M. Leyten et al. CLINICAL CANCER RESEARCH
- Re: Scott A. Tomlins, John R. Day, Robert J. Lonigro, et al. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.04.039
- (2015) Carsten Stephan et al. EUROPEAN UROLOGY
- A Multi-institutional Prospective Trial in the USA Confirms that the 4Kscore Accurately Identifies Men with High-grade Prostate Cancer
- (2015) Dipen J. Parekh et al. EUROPEAN UROLOGY
- Prospective Randomized Trial Comparing Magnetic Resonance Imaging (MRI)-guided In-bore Biopsy to MRI-ultrasound Fusion and Transrectal Ultrasound-guided Prostate Biopsy in Patients with Prior Negative Biopsies
- (2015) Christian Arsov et al. EUROPEAN UROLOGY
- Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer
- (2015) Tobias Nordström et al. EUROPEAN UROLOGY
- Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging–Ultrasound Fusion Targeted Biopsy: A Systematic Review
- (2015) Massimo Valerio et al. EUROPEAN UROLOGY
- Magnetic Resonance Imaging–targeted Biopsy May Enhance the Diagnostic Accuracy of Significant Prostate Cancer Detection Compared to Standard Transrectal Ultrasound-guided Biopsy: A Systematic Review and Meta-analysis
- (2015) Ivo G. Schoots et al. EUROPEAN UROLOGY
- Comparison of MR/Ultrasound Fusion–Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer
- (2015) M. Minhaj Siddiqui et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- PCA3 in prostate cancer and tumor aggressiveness detection on 407 high-risk patients: a National Cancer Institute experience
- (2015) Roberta Merola et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Multicenter Evaluation of the Prostate Health Index to Detect Aggressive Prostate Cancer in Biopsy Naïve Men
- (2015) Claire de la Calle et al. JOURNAL OF UROLOGY
- Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study
- (2015) Henrik Grönberg et al. LANCET ONCOLOGY
- Predicting prostate biopsy results—PCA3 versus phi
- (2015) Stacy Loeb Nature Reviews Urology
- The role of HOXC6 in prostate cancer development
- (2015) Agus Rizal A. H. Hamid et al. PROSTATE
- Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis
- (2014) K. S. Louie et al. ANNALS OF ONCOLOGY
- The Added Value of Percentage of Free to Total Prostate-specific Antigen, PCA3, and a Kallikrein Panel to the ERSPC Risk Calculator for Prostate Cancer in Prescreened Men
- (2014) Moniek M. Vedder et al. EUROPEAN UROLOGY
- Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer?
- (2014) John T. Wei et al. JOURNAL OF CLINICAL ONCOLOGY
- Cost-effectiveness of Prostate Cancer Screening: A Simulation Study Based on ERSPC Data
- (2014) E. A. M. Heijnsdijk et al. JNCI-Journal of the National Cancer Institute
- Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
- (2014) Fritz H Schröder et al. LANCET
- Accuracy of the prostate health index versus the urinary prostate cancer antigen 3 score to predict overall and significant prostate cancer at initial biopsy
- (2014) Thomas Seisen et al. PROSTATE
- Prostate Cancer Prevention Trial Risk Calculator 2.0 for the Prediction of Low- vs High-grade Prostate Cancer
- (2014) Donna P. Ankerst et al. UROLOGY
- PCA3 and PCA3-Based Nomograms Improve Diagnostic Accuracy in Patients Undergoing First Prostate Biopsy
- (2013) Alain Ruffion et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PCA3 Molecular Urine Test as a Predictor of Repeat Prostate Biopsy Outcome in Men with Previous Negative Biopsies: A Prospective Multicenter Clinical Study
- (2013) Marc C. Gittelman et al. JOURNAL OF UROLOGY
- Urinary PCA3 as a Predictor of Prostate Cancer in a Cohort of 3,073 Men Undergoing Initial Prostate Biopsy
- (2013) K. Kent Chevli et al. JOURNAL OF UROLOGY
- Initial Prostate Biopsy: Development and Internal Validation of a Biopsy-specific Nomogram Based on the Prostate Cancer Antigen 3 Assay
- (2012) Jens Hansen et al. EUROPEAN UROLOGY
- Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer
- (2012) Gisele H.J.M. Leyten et al. EUROPEAN UROLOGY
- Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA
- (2011) S. A. Tomlins et al. Science Translational Medicine
- Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group
- (2011) Monique J. Roobol et al. WORLD JOURNAL OF UROLOGY
- Prostate Cancer Gene 3 (PCA3): Development and Internal Validation of a Novel Biopsy Nomogram
- (2009) Felix K. Chun et al. EUROPEAN UROLOGY
- A Risk-Based Strategy Improves Prostate-Specific Antigen–Driven Detection of Prostate Cancer
- (2009) Monique J. Roobol et al. EUROPEAN UROLOGY
- Predictive value of PCA3 in urinary sediments in determining clinico-pathological characteristics of prostate cancer
- (2009) Daphne Hessels et al. PROSTATE
- Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy
- (2008) Alexander Haese et al. EUROPEAN UROLOGY
- Predicting Prostate Cancer Risk Through Incorporation of Prostate Cancer Gene 3
- (2008) Donna Pauler Ankerst et al. JOURNAL OF UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search